38 related articles for article (PubMed ID: 8312101)
1. Clinical trials referral resource. Current clinical trials of cilengitide, an alpha(v) antagonist in clinical development as an anticancer agent.
Colevas AD; Scharf O; Schoenfeldt M
Oncology (Williston Park); 2004 Dec; 18(14):1778, 1781-2, 1784. PubMed ID: 15700626
[No Abstract] [Full Text] [Related]
2. New anticancer agents.
Weiss GR; Burris HA; Eckardt JR; Fields S; Johnson R; O'Rourke T; Rodriguez GI; Rothenberg ML; Wall J
Cancer Chemother Biol Response Modif; 1993; 14():118-28. PubMed ID: 8312101
[No Abstract] [Full Text] [Related]
3. Novel therapeutic applications of cardiac glycosides.
Prassas I; Diamandis EP
Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999
[TBL] [Abstract][Full Text] [Related]
4. Farnesyltransferase inhibitors as anticancer agents: critical crossroads.
Doll RJ; Kirschmeier P; Bishop WR
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):478-86. PubMed ID: 15338957
[TBL] [Abstract][Full Text] [Related]
5. [Antimitochondrial agents: a new class of anticancer agents].
André N; Rome A; Carré M;
Arch Pediatr; 2006 Jan; 13(1):69-75. PubMed ID: 16298120
[TBL] [Abstract][Full Text] [Related]
6. Emerging DNA topisomerase inhibitors as anticancer drugs.
Denny WA
Expert Opin Emerg Drugs; 2004 May; 9(1):105-33. PubMed ID: 15155139
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors: from bench to clinic.
Paris M; Porcelloni M; Binaschi M; Fattori D
J Med Chem; 2008 Mar; 51(6):1505-29. PubMed ID: 18247554
[No Abstract] [Full Text] [Related]
8. Farnesyltransferase inhibitors as anticancer agents: current status.
Zhu K; Hamilton AD; Sebti SM
Curr Opin Investig Drugs; 2003 Dec; 4(12):1428-35. PubMed ID: 14763128
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
